
Quantum Intelligence Corp is a South Korea-based company founded in 2020 that develops an AI-driven drug discovery platform called QUEST. This platform integrates quantum mechanics, chemistry, and artificial intelligence to predict and optimize new drug candidates, including small compounds and peptide drugs, by analyzing 3D electrostatic potentials and molecular structures. QUEST enables accurate prediction of chemical properties such as permeability, solubility, and stability without wet lab experiments, accelerating early-stage drug development. The company leverages advanced neural network models and GPU clusters to achieve high-accuracy ligand docking and drug property predictions, positioning itself as a cutting-edge innovator in computational drug discovery.

Quantum Intelligence Corp is a South Korea-based company founded in 2020 that develops an AI-driven drug discovery platform called QUEST. This platform integrates quantum mechanics, chemistry, and artificial intelligence to predict and optimize new drug candidates, including small compounds and peptide drugs, by analyzing 3D electrostatic potentials and molecular structures. QUEST enables accurate prediction of chemical properties such as permeability, solubility, and stability without wet lab experiments, accelerating early-stage drug development. The company leverages advanced neural network models and GPU clusters to achieve high-accuracy ligand docking and drug property predictions, positioning itself as a cutting-edge innovator in computational drug discovery.